Characteristics and clinical assessment of antibiotic delivery by chitosan sponge in the high-risk diabetic foot: A case series

N. Patel, D. Hatch, C. M. Wells, D. Ahn, M. Harris, J. A. Jennings, W. Haggard, David G Armstrong

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: The local delivery of antimicrobials is attractive for a number of reasons. Chitosan, a biodegradable polysaccharide sponge material, has been proposed as medium to deliver antibiotics directly to wounds. In this report we evaluate the safety and practicality of antimicrobial delivery via chitosan sponge. Method: We present the clinical course and systemic absorption characteristics of three cases of people with diabetic foot wounds treated with antibiotic soaked chitosan sponge (Sentrex BioSponge, Bionova Medical, Germantown, TN). The antibiotic sponge was made by reconstituting 1.2g tobramycin or 100mg doxycycline in 10-15ml saline and saturating the sponge with the solution. The sponge was then applied to the wounds. Serum levels of each respective antibiotic were evaluated after application. Additional in vitro studies were conducted evaluating elution of antibiotics from the chitosan sponge at established minimum inhibitory concentrations (MIC) for Staphylococcus aureus over 28 days. Results: No patient experienced adverse local or systemic effects due to the sponge treatment. The measured serum levels applied antibiotics remained far less than established minimums after intravenous therapy. Each patient required further treatment, however local infection or contamination resolved during the course of their hospital stay after the chitosan/antibiotic application. Conclusion: The use of antibiotic-impregnated chitosan sponges appears a safe and effective mechanism of local delivery of antimicrobials in wounds. Future studies and clinical trials are ongoing to confirm these results and to guide clinical applications.

Original languageEnglish (US)
Pages (from-to)S32-S38
JournalJournal of wound care
Volume26
DOIs
StatePublished - Apr 1 2017

Fingerprint

Diabetic Foot
Chitosan
Porifera
Anti-Bacterial Agents
Wounds and Injuries
Tobramycin
Doxycycline
Microbial Sensitivity Tests
Serum
Polysaccharides
Staphylococcus aureus
Length of Stay
Therapeutics
Clinical Trials
Safety

Keywords

  • Antibacterial agents
  • Chitosan
  • Diabetic foot
  • Staphylococcus aureus
  • Wound healing
  • Wound infection

ASJC Scopus subject areas

  • Fundamentals and skills
  • Nursing (miscellaneous)

Cite this

Characteristics and clinical assessment of antibiotic delivery by chitosan sponge in the high-risk diabetic foot : A case series. / Patel, N.; Hatch, D.; Wells, C. M.; Ahn, D.; Harris, M.; Jennings, J. A.; Haggard, W.; Armstrong, David G.

In: Journal of wound care, Vol. 26, 01.04.2017, p. S32-S38.

Research output: Contribution to journalArticle

Patel, N. ; Hatch, D. ; Wells, C. M. ; Ahn, D. ; Harris, M. ; Jennings, J. A. ; Haggard, W. ; Armstrong, David G. / Characteristics and clinical assessment of antibiotic delivery by chitosan sponge in the high-risk diabetic foot : A case series. In: Journal of wound care. 2017 ; Vol. 26. pp. S32-S38.
@article{bf3968f4f6e842b895556bd0d7a4a8b2,
title = "Characteristics and clinical assessment of antibiotic delivery by chitosan sponge in the high-risk diabetic foot: A case series",
abstract = "Objective: The local delivery of antimicrobials is attractive for a number of reasons. Chitosan, a biodegradable polysaccharide sponge material, has been proposed as medium to deliver antibiotics directly to wounds. In this report we evaluate the safety and practicality of antimicrobial delivery via chitosan sponge. Method: We present the clinical course and systemic absorption characteristics of three cases of people with diabetic foot wounds treated with antibiotic soaked chitosan sponge (Sentrex BioSponge, Bionova Medical, Germantown, TN). The antibiotic sponge was made by reconstituting 1.2g tobramycin or 100mg doxycycline in 10-15ml saline and saturating the sponge with the solution. The sponge was then applied to the wounds. Serum levels of each respective antibiotic were evaluated after application. Additional in vitro studies were conducted evaluating elution of antibiotics from the chitosan sponge at established minimum inhibitory concentrations (MIC) for Staphylococcus aureus over 28 days. Results: No patient experienced adverse local or systemic effects due to the sponge treatment. The measured serum levels applied antibiotics remained far less than established minimums after intravenous therapy. Each patient required further treatment, however local infection or contamination resolved during the course of their hospital stay after the chitosan/antibiotic application. Conclusion: The use of antibiotic-impregnated chitosan sponges appears a safe and effective mechanism of local delivery of antimicrobials in wounds. Future studies and clinical trials are ongoing to confirm these results and to guide clinical applications.",
keywords = "Antibacterial agents, Chitosan, Diabetic foot, Staphylococcus aureus, Wound healing, Wound infection",
author = "N. Patel and D. Hatch and Wells, {C. M.} and D. Ahn and M. Harris and Jennings, {J. A.} and W. Haggard and Armstrong, {David G}",
year = "2017",
month = "4",
day = "1",
doi = "10.12968/jowc.2017.26.Sup4.S32",
language = "English (US)",
volume = "26",
pages = "S32--S38",
journal = "Journal of wound care",
issn = "0969-0700",
publisher = "MA Healthcare Ltd",

}

TY - JOUR

T1 - Characteristics and clinical assessment of antibiotic delivery by chitosan sponge in the high-risk diabetic foot

T2 - A case series

AU - Patel, N.

AU - Hatch, D.

AU - Wells, C. M.

AU - Ahn, D.

AU - Harris, M.

AU - Jennings, J. A.

AU - Haggard, W.

AU - Armstrong, David G

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Objective: The local delivery of antimicrobials is attractive for a number of reasons. Chitosan, a biodegradable polysaccharide sponge material, has been proposed as medium to deliver antibiotics directly to wounds. In this report we evaluate the safety and practicality of antimicrobial delivery via chitosan sponge. Method: We present the clinical course and systemic absorption characteristics of three cases of people with diabetic foot wounds treated with antibiotic soaked chitosan sponge (Sentrex BioSponge, Bionova Medical, Germantown, TN). The antibiotic sponge was made by reconstituting 1.2g tobramycin or 100mg doxycycline in 10-15ml saline and saturating the sponge with the solution. The sponge was then applied to the wounds. Serum levels of each respective antibiotic were evaluated after application. Additional in vitro studies were conducted evaluating elution of antibiotics from the chitosan sponge at established minimum inhibitory concentrations (MIC) for Staphylococcus aureus over 28 days. Results: No patient experienced adverse local or systemic effects due to the sponge treatment. The measured serum levels applied antibiotics remained far less than established minimums after intravenous therapy. Each patient required further treatment, however local infection or contamination resolved during the course of their hospital stay after the chitosan/antibiotic application. Conclusion: The use of antibiotic-impregnated chitosan sponges appears a safe and effective mechanism of local delivery of antimicrobials in wounds. Future studies and clinical trials are ongoing to confirm these results and to guide clinical applications.

AB - Objective: The local delivery of antimicrobials is attractive for a number of reasons. Chitosan, a biodegradable polysaccharide sponge material, has been proposed as medium to deliver antibiotics directly to wounds. In this report we evaluate the safety and practicality of antimicrobial delivery via chitosan sponge. Method: We present the clinical course and systemic absorption characteristics of three cases of people with diabetic foot wounds treated with antibiotic soaked chitosan sponge (Sentrex BioSponge, Bionova Medical, Germantown, TN). The antibiotic sponge was made by reconstituting 1.2g tobramycin or 100mg doxycycline in 10-15ml saline and saturating the sponge with the solution. The sponge was then applied to the wounds. Serum levels of each respective antibiotic were evaluated after application. Additional in vitro studies were conducted evaluating elution of antibiotics from the chitosan sponge at established minimum inhibitory concentrations (MIC) for Staphylococcus aureus over 28 days. Results: No patient experienced adverse local or systemic effects due to the sponge treatment. The measured serum levels applied antibiotics remained far less than established minimums after intravenous therapy. Each patient required further treatment, however local infection or contamination resolved during the course of their hospital stay after the chitosan/antibiotic application. Conclusion: The use of antibiotic-impregnated chitosan sponges appears a safe and effective mechanism of local delivery of antimicrobials in wounds. Future studies and clinical trials are ongoing to confirm these results and to guide clinical applications.

KW - Antibacterial agents

KW - Chitosan

KW - Diabetic foot

KW - Staphylococcus aureus

KW - Wound healing

KW - Wound infection

UR - http://www.scopus.com/inward/record.url?scp=85017632197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017632197&partnerID=8YFLogxK

U2 - 10.12968/jowc.2017.26.Sup4.S32

DO - 10.12968/jowc.2017.26.Sup4.S32

M3 - Article

C2 - 28379101

AN - SCOPUS:85017632197

VL - 26

SP - S32-S38

JO - Journal of wound care

JF - Journal of wound care

SN - 0969-0700

ER -